Syneos Health acquires Illingworth Research Group
Deal bolsters company's decentralized trials and patient-focus reach
Syneos Health, a biopharma solutions organization, has acquired Illingworth Research Group, a clinical research home health services provider.
Illingworth's specialization is in-home and on-site research nursing services (including mobile research nursing) for clinical trials. The company works with biopharma and medical device companies supporting studies in more than 46 countries. The current pandemic has further accelerated the demand for these types of offerings. Illingworth also provides complementary patient-focused contract research organization (CRO) services aimed at decreasing patient and site burden, and has experience across Phase I–IV studies in therapeutic segments such as oncology, respiratory, rare disease and pediatrics.
The deal adds additional capabilities to Syneos's decentralized clinical trial solutions.
Illingworth will maintain its brand name, but will operate as a part of Syneos Health.
